IZINV.E — Iz Hayvancilik Tarim ve Gida Sanayi Ticaret AS Balance Sheet
0.000.00%
- TRY1.14bn
- TRY1.13bn
- TRY85.62m
- 14
- 11
- 60
- 14
Annual balance sheet for Iz Hayvancilik Tarim ve Gida Sanayi Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.189 | 0.344 | 1.54 | 37.4 | 12.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.11 | 8.57 | 24.3 | 14.8 | 24.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16.1 | 22.5 | 35.4 | 64.6 | 87 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 52.7 | 50.8 | 162 | 27.7 | 26.2 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 71 | 76.1 | 232 | 426 | 394 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 26.1 | 39.5 | 18.6 | 12.7 | 14.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 39.9 | 51.4 | 45.9 | 184 | 78.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 31.1 | 24.8 | 186 | 242 | 315 |
| Total Liabilities & Shareholders' Equity | 71 | 76.1 | 232 | 426 | 394 |
| Total Common Shares Outstanding |